FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 358:105-107 January 10, 2008 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Audio Interview Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

It may happen soon. A patient, perhaps one you have known for years, who is overweight and does not exercise regularly, shows up in your office with an analysis of his whole genome at multiple single-nucleotide polymorphisms (SNPs). His children, who were concerned about his health, spent $1,000 to give him the analysis as a holiday gift. The test report states that his genomic profile is consistent with an increased risk of both heart disease and diabetes, and because the company that performed the analysis stated that the test was "not a clinical service to be used as the basis . . . [Full Text of this Article]

Source Information

Dr. Hunter is a professor in the Departments of Epidemiology and Nutrition at the Harvard School of Public Health, Boston, and a statistical consultant to the Journal. Dr. Khoury is the director of the National Office of Public Health Genomics at the Centers for Disease Control and Prevention, Atlanta. Dr. Drazen is the editor-in-chief of the Journal. The opinions expressed in this article do not necessarily reflect the views of the Department of Health and Human Services.

An interview with Dr. Muin Khoury, director of the National Office of Public Health Genomics at the Centers for Disease Control and Prevention, can be heard at www.nejm.org.

Related Letters:

Letting the Genome Out of the Bottle
Haga S. B., Willard H. F., Audeh M. W., Hunter D. J., Khoury M. J., Drazen J. M.
Extract | Full Text | PDF  
N Engl J Med 2008; 358:2184-2185, May 15, 2008. Correspondence

This article has been cited by other articles:

• Pereira, T. V., Patsopoulos, N. A., Salanti, G., Ioannidis, J. P. A. (2009). Discovery Properties of Genome-wide Association Signals From Cumulatively Combined Data Sets. Am J Epidemiol 170: 1197-1206 [Abstract] [Full Text]  
• Simon, R. M., Paik, S., Hayes, D. F. (2009). Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers. JNCI J Natl Cancer Inst 101: 1446-1452 [Abstract] [Full Text]  
• Kapa, S., Tester, D. J., Salisbury, B. A., Harris-Kerr, C., Pungliya, M. S., Alders, M., Wilde, A. A.M., Ackerman, M. J. (2009). Genetic Testing for Long-QT Syndrome: Distinguishing Pathogenic Mutations From Benign Variants. Circulation 120: 1752-1760 [Abstract] [Full Text]  
• Salanti, G., Southam, L., Altshuler, D., Ardlie, K., Barroso, I., Boehnke, M., Cornelis, M. C., Frayling, T. M., Grallert, H., Grarup, N., Groop, L., Hansen, T., Hattersley, A. T., Hu, F. B., Hveem, K., Illig, T., Kuusisto, J., Laakso, M., Langenberg, C., Lyssenko, V., McCarthy, M. I., Morris, A., Morris, A. D., Palmer, C. N. A., Payne, F., Platou, C. G. P., Scott, L. J., Voight, B. F., Wareham, N. J., Zeggini, E., Ioannidis, J. P. A. (2009). Underlying Genetic Models of Inheritance in Established Type 2 Diabetes Associations. Am J Epidemiol 170: 537-545 [Abstract] [Full Text]  
• Khoury, M. J., Bertram, L., Boffetta, P., Butterworth, A. S., Chanock, S. J., Dolan, S. M., Fortier, I., Garcia-Closas, M., Gwinn, M., Higgins, J. P. T., Janssens, A. C. J. W., Ostell, J., Owen, R. P., Pagon, R. A., Rebbeck, T. R., Rothman, N., Bernstein, J. L., Burton, P. R., Campbell, H., Chockalingam, A., Furberg, H., Little, J., O'Brien, T. R., Seminara, D., Vineis, P., Winn, D. M., Yu, W., Ioannidis, J. P. A. (2009). Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases. Am J Epidemiol 170: 269-279 [Abstract] [Full Text]  
• Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., Eckert, S. L., Butson, M., Sadovnick, A. D., Quaid, K. A., Chen, C., Cook-Deegan, R., Farrer, L. A., the REVEAL Study Group, (2009). Disclosure of APOE Genotype for Risk of Alzheimer's Disease. NEJM 361: 245-254 [Abstract] [Full Text]  
• Farkas, D. H., Holland, C. A. (2009). Direct-to-Consumer Genetic Testing: Two Sides of the Coin. J. Mol. Diagn. 11: 263-265 [Full Text]  
• Marietta, C., McGuire, A. L. (2009). Currents in Contemporary Ethics: Direct-to-Consumer Genetic Testing: Is It the Practice of Medicine?. J Law Med Ethics 37: 369-374  
• Shin, J., Kayser, S. R., Langaee, T. Y. (2009). Pharmacogenetics: from discovery to patient care. Am J Health Syst Pharm 66: 625-637 [Abstract] [Full Text]  
• Roukos, D. H. (2009). Twenty-One-Gene Assay: Challenges and Promises in Translating Personal Genomics and Whole-Genome Scans Into Personalized Treatment of Breast Cancer. JCO 27: 1337-1338 [Full Text]  
• Ding, K., Kullo, I. J. (2009). Genome-wide Association Studies for Atherosclerotic Vascular Disease and Its Risk Factors.. Circ Cardiovasc Genet 2: 63-72 [Full Text]  
• Bloomgarden, Z. T. (2009). Topics in Type 2 Diabetes and Insulin Resistance. Diabetes Care 32: e13-e19 [Full Text]  
• Attia, J., Ioannidis, J. P. A., Thakkinstian, A., McEvoy, M., Scott, R. J., Minelli, C., Thompson, J., Infante-Rivard, C., Guyatt, G. (2009). How to Use an Article About Genetic Association: C: What Are the Results and Will They Help Me in Caring for My Patients?. JAMA 301: 304-308 [Abstract] [Full Text]  
• Ioannidis, J. P.A. (2009). Personalized Genetic Prediction: Too Limited, Too Expensive, or Too Soon?. ANN INTERN MED 150: 139-141 [Full Text]  
• McGuire, A. L., Burke, W. (2008). An Unwelcome Side Effect of Direct-to-Consumer Personal Genome Testing: Raiding the Medical Commons. JAMA 300: 2669-2671 [Full Text]  
• Meigs, J. B., Shrader, P., Sullivan, L. M., McAteer, J. B., Fox, C. S., Dupuis, J., Manning, A. K., Florez, J. C., Wilson, P. W.F., D'Agostino, R. B. Sr., Cupples, L. A. (2008). Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes. NEJM 359: 2208-2219 [Abstract] [Full Text]  
• Henderson, G. E. (2008). Introducing Social and Ethical Perspectives on Gene--Environment Research. Sociological Methods Research 37: 251-276 [Abstract]  
• Topol, E. J (2008). Genome scanning and cardiovascular disease. Heart 94: 1361-1363 [Full Text]  
• Kaye, J. (2008). The regulation of direct-to-consumer genetic tests. Hum Mol Genet 17: R180-R183 [Abstract] [Full Text]  
• Fujimura, J. H., Duster, T., Rajagopalan, R. (2008). Race, genetics, and disease: questions of evidence, matters of consequence.. Social Studies of Science 38: 643-656 [Abstract]  
• Weiss, K. M. (2008). Tilting at Quixotic Trait Loci (QTL): An Evolutionary Perspective on Genetic Causation. Genetics 179: 1741-1756 [Abstract] [Full Text]  
• Boulesteix, A.-L., Porzelius, C., Daumer, M. (2008). Microarray-based classification and clinical predictors: on combined classifiers and additional predictive value. Bioinformatics 24: 1698-1706 [Abstract] [Full Text]  
• Hall, F. M. (2008). The Rise and Impending Decline of Screening Mammography. Radiology 247: 597-601 [Full Text]  
• Haga, S. B., Willard, H. F., Audeh, M. W., Hunter, D. J., Khoury, M. J., Drazen, J. M. (2008). Letting the genome out of the bottle.. NEJM 358: 2184-2185 [Full Text]  
• Roth, S. M. (2008). Last Word on Viewpoint: Perspective on the future use of genomics in exercise prescription. J. Appl. Physiol. 104: 1254-1254 [Full Text]  
• Feero, W. G., Guttmacher, A. E., Collins, F. S. (2008). The Genome Gets Personal--Almost. JAMA 299: 1351-1352 [Full Text]